E-LIB Suche - Ergebnisse für: Hirasawa, Yosuke

1

Durable Response to Enfortumab Vedotin Compared to Re-chall..:

Uchimoto, Taizo ; Tsuchida, Shuya ; Komura, Kazumasa...
Targeted Oncology. 19 (2024) 3 - p. 401-410 , 2024

2

Comparison of the efficacy of enfortumab vedotin between pa..:

Hirasawa, Yosuke ; Adachi, Takahiro ; Hashimoto, Takeshi...
Journal of Cancer Research and Clinical Oncology. 150 (2024) 4 - p. , 2024

Link: https://doi.org/10.1007/..

3

Prognostic Impact of Immune-Related Adverse Events as First..:

Nukaya, Takuhisa ; Takahara, Kiyoshi ; Yoshizawa, Atsuhiko...
Clinical Genitourinary Cancer. 22 (2024) 1 - p. 76-83 , 2024

Link: https://doi.org/10.1016/..

4

C-Reactive Protein-Albumin Ratio Predicts Objective Respons..:

Uchimoto, Taizo ; Matsuda, Takuya ; Komura, Kazumasa...
Targeted Oncology. 19 (2024) 4 - p. 635-644 , 2024

Link: https://doi.org/10.1007/..

5

Nephron-sparing ureteroscopic surgery vs. radical nephroure..:

Tsujino, Takuya ; Komura, Kazumasa ; Inamoto, Teruo...
World Journal of Urology. 41 (2023) 12 - p. 3585-3591 , 2023

Link: https://doi.org/10.1007/..

6

Real world evidence of enfortumab vedotin in patients with ..:

Fukuokaya, Wataru ; Koike, Yuhei ; Yata, Yuji...
International Journal of Urology. 31 (2023) 4 - p. 342-347 , 2023

Link: https://doi.org/10.1111/..

7

Concurrent palliative radiation with pembrolizumab for plat..:

Nakamori, Keita ; Yamazaki, Shogo ; Komura, Kazumasa...
Clinical and Translational Radiation Oncology. 39 (2023) - p. 100558 , 2023

Link: https://doi.org/10.1016/..

8

Clinical value of minimum apparent diffusion coefficient fo..:

Ono, Ashita ; Hashimoto, Takeshi ; Shishido, Toshihide...
International Journal of Clinical Oncology. 28 (2023) 5 - p. 716-723 , 2023

Link: https://doi.org/10.1007/..

9

Real‑world survival outcome comparing abiraterone acetate p..:

Tsujino, Takuya ; Tokushige, Satoshi ; Komura, Kazumasa...
Cancer Medicine. 12 (2023) 19 - p. 19414-19422 , 2023

Link: https://doi.org/10.1002/..

10

Serum C-reactive Protein Level Predicts Overall Survival fo..:

Yano, Yusuke ; Ohno, Takaya ; Komura, Kazumasa...
Cancers. 14 (2022) 22 - p. 5659 , 2022

Link: https://doi.org/10.3390/..

11

Diagnostic performance of Oncuria™, a urinalysis test for b..:

Hirasawa, Yosuke ; Pagano, Ian ; Chen, Runpu...
Journal of Translational Medicine. 19 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

12

Phase Ib study of patients with metastatic castrate-resista..:

Dorff, Tanya ; Hirasawa, Yosuke ; Acoba, Jared...
Journal for ImmunoTherapy of Cancer. 9 (2021) 8 - p. e002931 , 2021

Link: https://doi.org/10.1136/..

13

Prognostic significance of the presence of tertiary Gleason..:

Kamoda, Naohiro ; Ohori, Makoto ; Hirasawa, Yosuke...
Japanese Journal of Clinical Oncology. 49 (2019) 3 - p. 276-280 , 2019

Link: https://doi.org/10.1093/..

14

Salvage radiation therapy for prostate cancer patients afte..:

Mima, Takashi ; Ohori, Makoto ; Hirasawa, Yosuke...
Japanese Journal of Clinical Oncology. 49 (2019) 3 - p. 281-286 , 2019

Link: https://doi.org/10.1093/..

15

Prostate‐specific antigen screening impacts on biochemical ..:

Hashimoto, Takeshi ; Ohori, Makoto ; Shimodaira, Kenji...
International Journal of Urology. 25 (2018) 6 - p. 561-567 , 2018

Link: https://doi.org/10.1111/..